利妥昔单抗是否应用于治疗抗中性粒细胞胞浆抗体相关性血管炎？
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
作者信息
Flossmann O, Jones R B, Jayne D R W, Luqmani R A
出版信息
Ann Rheum Dis. 2006 Jul;65(7):841-4. doi: 10.1136/ard.2005.048900.
Abstract
It remains to be seen whether rituximab can live up to the high expectations and offer a more effective treatment for patients with AASV
摘要
利妥昔单抗是否能不负众望，为抗中性粒细胞胞浆抗体相关性血管炎（AASV）患者提供更有效的治疗，仍有待观察。
相似文献
1
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?利妥昔单抗是否应用于治疗抗中性粒细胞胞浆抗体相关性血管炎？
Ann Rheum Dis. 2006 Jul;65(7):841-4. doi: 10.1136/ard.2005.048900.
2
Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.第2部分：抗中性粒细胞胞浆抗体相关性血管炎的B淋巴细胞靶向治疗概述
Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S74-6.
3
Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases.利妥昔单抗成功诱导肾移植后抗中性粒细胞胞浆抗体相关性血管炎复发的缓解：两例报告
Am J Transplant. 2007 Dec;7(12):2821-5. doi: 10.1111/j.1600-6143.2007.01985.x. Epub 2007 Oct 1.
4
Targeting the B cell in vasculitis.针对血管炎中的B细胞。
Pediatr Nephrol. 2009 Jul;24(7):1267-75. doi: 10.1007/s00467-008-1010-z. Epub 2008 Oct 18.
5
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.9例抗中性粒细胞胞浆抗体阳性血管炎患者接受利妥昔单抗治疗成功。
J Intern Med. 2005 Jun;257(6):540-8. doi: 10.1111/j.1365-2796.2005.01494.x.
6
[Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].[血管炎的治疗：抗中性粒细胞胞浆抗体（ANCA）的发现]
Presse Med. 2007 May;36(5 Pt 2):843-4. doi: 10.1016/j.lpm.2007.04.006.
7
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.一项关于利妥昔单抗治疗难治性抗中性粒细胞胞浆抗体相关性血管炎的多中心调查。
Arthritis Rheum. 2009 Jul;60(7):2156-68. doi: 10.1002/art.24637.
8
Inflammation: Rituximab in ANCA vasculitis and lupus: bittersweet results.炎症：利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎和狼疮：喜忧参半的结果。
Nat Rev Nephrol. 2010 Mar;6(3):137-9. doi: 10.1038/nrneph.2010.13.
9
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.11例难治性抗中性粒细胞胞浆抗体相关性血管炎患者通过B淋巴细胞清除实现缓解。
Arthritis Rheum. 2005 Jan;52(1):262-8. doi: 10.1002/art.20718.
10
Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关血管炎和系统性红斑狼疮：过去、现在与未来
Kidney Int. 2007 Sep;72(6):676-82. doi: 10.1038/sj.ki.5002395. Epub 2007 Jul 4.
引用本文的文献
1
Unmet Needs in the Pathogenesis and Treatment of Vasculitides.血管炎发病机制和治疗中的未满足需求。
Clin Rev Allergy Immunol. 2018 Apr;54(2):244-260. doi: 10.1007/s12016-017-8643-2.
2
Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?类风湿性血管炎会先于类风湿关节炎的诊断出现吗？
Eur J Rheumatol. 2017 Mar;4(1):57-58. doi: 10.5152/eurjrheum.2017.160058. Epub 2017 Mar 1.
3
An approach to the diagnosis and management of systemic vasculitis.系统性血管炎的诊断与治疗方法。
Clin Exp Immunol. 2010 May;160(2):143-60. doi: 10.1111/j.1365-2249.2009.04078.x. Epub 2010 Jan 12.
4
[Wegener's granulomatosis and microscopic polyangiitis].[韦格纳肉芽肿病和显微镜下多血管炎]
Z Rheumatol. 2009 Feb;68(1):49-63; quiz 64. doi: 10.1007/s00393-008-0425-z.
5
Lymphocyte counts in patients with ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎患者的淋巴细胞计数
Rheumatol Int. 2009 May;29(7):807-10. doi: 10.1007/s00296-008-0762-x. Epub 2008 Nov 8.
6
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.坏死性和新月体性肾小球肾炎中的抗中性粒细胞胞浆抗体（ANCA）和抗肾小球基底膜抗体（GBM）
Semin Immunopathol. 2007 Nov;29(4):459-74. doi: 10.1007/s00281-007-0093-0. Epub 2007 Oct 18.
本文引用的文献
1
Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.利妥昔单抗治疗难治性系统性红斑狼疮和血管炎的长期比较：缓解、复发及再治疗
Arthritis Rheum. 2006 Sep;54(9):2970-82. doi: 10.1002/art.22046.
2
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.系统性红斑狼疮中的B淋巴细胞刺激因子（BLyS）亚型：疾病活动与血液白细胞BLyS mRNA水平的相关性优于与血浆BLyS蛋白水平的相关性。
Arthritis Res Ther. 2006;8(1):R6. doi: 10.1186/ar1855.
3
B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.韦格纳肉芽肿中B淋巴细胞的成熟：来自鼻内病变VH基因的比较分析
Ann Rheum Dis. 2006 Jul;65(7):859-64. doi: 10.1136/ard.2005.044909. Epub 2005 Nov 16.
4
Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.利妥昔单抗治疗伴有难治性肉芽肿表现的韦格纳肉芽肿无效。
Ann Rheum Dis. 2006 Jul;65(7):853-8. doi: 10.1136/ard.2005.044420. Epub 2005 Nov 3.
5
BAFF is elevated in serum of patients with Wegener's granulomatosis.在韦格纳肉芽肿患者的血清中，B淋巴细胞刺激因子水平升高。
J Autoimmun. 2005 Dec;25(4):298-302. doi: 10.1016/j.jaut.2005.08.004. Epub 2005 Oct 20.
6
Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.利妥昔单抗治疗难治性韦格纳肉芽肿：一项前瞻性、开放标签的试点试验报告。
Am J Respir Crit Care Med. 2006 Jan 15;173(2):180-7. doi: 10.1164/rccm.200507-1144OC. Epub 2005 Oct 13.
7
Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.抗CD20疗法治疗难治性韦格纳肉芽肿：疗效良好但反应短暂。
Scand J Rheumatol. 2005 May-Jun;34(3):229-32. doi: 10.1080/02813430510015269.
8
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.9例抗中性粒细胞胞浆抗体阳性血管炎患者接受利妥昔单抗治疗成功。
J Intern Med. 2005 Jun;257(6):540-8. doi: 10.1111/j.1365-2796.2005.01494.x.
9
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.11例难治性抗中性粒细胞胞浆抗体相关性血管炎患者通过B淋巴细胞清除实现缓解。
Arthritis Rheum. 2005 Jan;52(1):262-8. doi: 10.1002/art.20718.
10
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.利妥昔单抗对43例系统性自身免疫性疾病患者的耐受性及短期疗效
Ann Rheum Dis. 2005 Jun;64(6):913-20. doi: 10.1136/ard.2004.029694. Epub 2004 Nov 18.
Zotero 插件